Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
24 items
National Eye Institute logo.

Phase 1 Clinical Trial Results of Gene Transfer for Leber Congenital Amaurosis Reported

Three young adults with Leber Congenital Amaurosis-a severe degenerative disease of the retina caused by a mutation in the RPE65 gene-reported improvements in vision after undergoing a specialized gene transfer procedure.
National Eye Institute logo.

Gene Transfer for Leber Congenital Amaurosis

Two groups of investigators have reported independently on their initial observations from Phase I clinical trials of gene transfer for Leber congenital amaurosis (LCA) caused by mutations in the RPE65 gene.
National Eye Institute logo.

Statement on Clinical Trial of Gene Transfer Therapy for Childhood-Onset Blindness

The National Eye Institute (NEI) of the National Institutes of Health (NIH) is supporting a phase I clinical trial to assess the safety of gene transfer in treating people with a form of Leber congenital amaurosis (LCA).
National Eye Institute logo.

Defective Mouse Gene Linked to Childhood Blindness

For centuries, children have been reciting the Mother Goose nursery rhyme, “Three Blind Mice.” Now, researchers studying a new strain of blind mice may know what caused their blindness and, more importantly, how this knowledge might someday prevent some..